Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Patient Derived Cancer Cell Lines in Identifying Molecular Changes in Patients With Previously Untreated Pancreatic Cancer Receiving Gemcitabine Hydrochloride-Based Chemotherapy
- Status
- WITHDRAWN
- Phase
- N/A
A Dose-Finding Study of Birabresib (MK-8628), a Small Molecule Inhibitor of the Bromodomain and Extra-Terminal (BET) Proteins, in Adults With Selected Advanced Solid Tumors (MK-8628-003)
- Status
- COMPLETED
- Phase
- PHASE1
Plasma Biomarkers P-DAC, V1
- Status
- TERMINATED
- Phase
- N/A
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation
- Status
- COMPLETED
- Phase
- PHASE2
A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Phase 0 Biodistribution of Novel Imaging for Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas
- Status
- UNKNOWN
- Phase
- N/A
A Biomarker Study to Identify Predictive Signatures of Response to LDE225 (Hedgehog Inhibitor) In Patients With Resectable Pancreatic Cancer
- Status
- WITHDRAWN
- Phase
- NA
Pilot Study Evaluating Broccoli Sprouts in Advanced Pancreatic Cancer [POUDER Trial]
- Status
- UNKNOWN
- Phase
- NA
A Phase 2 Study of siG12D LODER in Combination With Chemotherapy in Patients With Locally Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Selumetinib and Akt Inhibitor MK2206 or mFOLFOX Therapy Comprising Oxaliplatin and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide and Gemcitabine as First-line Treatment in Patients With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine + Nab-paclitaxel With LDE-225 (Hedgehog Inhibitor) as Neoadjuvant Therapy for Pancreatic Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Carboplatin and Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase I - Escalating Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Locally Advanced Adenocarcinoma of the Pancreas, and a Single Dose Study of siG12D LODER (Local Drug EluteR) in Patients With Non-operable Adenocarcinoma of the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1
Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS)
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1